Loading...
•
Jun 30, 2022
OrthoPediatrics Q2 2022 Earnings Report
OrthoPediatrics reported record revenue with a 23% increase year-over-year and record adjusted EBITDA.
Key Takeaways
OrthoPediatrics Corp. announced its Q2 2022 financial results, highlighted by a 23% increase in total revenue to $32.9 million and a record adjusted EBITDA of $2.1 million. The company also increased its full-year 2022 revenue guidance to a range of $127 million to $130 million.
Helped over 23,000 children in the second quarter 2022, bringing total to more than 560,000 since the inception of OrthoPediatrics.
Total revenue for the second quarter of 2022 was $32.9 million, a 23% increase compared to $26.7 million for the same period last year.
Generated record Adjusted EBITDA of $2.1 million in the second quarter of 2022, compared to $1.2 million in the second quarter of 2021.
Increased full year 2022 revenue guidance to a range of $127 million to $130 million, from its previous guidance range of $125 million to $128 million, representing growth of 30% to 33% compared to the prior year
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company now expects its full year revenue to be in the range of $127 million to $130 million, representing growth of 30% to 33% over 2021 revenue.
Positive Outlook
- Full year revenue is expected to be in the range of $127 million to $130 million.
- Revenue, excluding recent acquisitions, is expected to be in the range of $118 million to $121 million.
- Annual set deployment of $24 million to $26 million is expected.
- The company expects to generate several million dollars of adjusted EBITDA for full year 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...